1314 related articles for article (PubMed ID: 24625896)
1. Bile acids and the gut microbiome.
Ridlon JM; Kang DJ; Hylemon PB; Bajaj JS
Curr Opin Gastroenterol; 2014 May; 30(3):332-8. PubMed ID: 24625896
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut.
Ridlon JM; Kang DJ; Hylemon PB; Bajaj JS
Dig Dis; 2015; 33(3):338-45. PubMed ID: 26045267
[TBL] [Abstract][Full Text] [Related]
3. The gut microbiome-bile acid axis in hepatocarcinogenesis.
Wu L; Feng J; Li J; Yu Q; Ji J; Wu J; Dai W; Guo C
Biomed Pharmacother; 2021 Jan; 133():111036. PubMed ID: 33378947
[TBL] [Abstract][Full Text] [Related]
4. The Role of the Gut Microbiota in Bile Acid Metabolism.
Ramírez-Pérez O; Cruz-Ramón V; Chinchilla-López P; Méndez-Sánchez N
Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s15-s20. PubMed ID: 29080339
[TBL] [Abstract][Full Text] [Related]
5. Interactions between gut bacteria and bile in health and disease.
Long SL; Gahan CGM; Joyce SA
Mol Aspects Med; 2017 Aug; 56():54-65. PubMed ID: 28602676
[TBL] [Abstract][Full Text] [Related]
6. Bile acids as metabolic regulators.
Li T; Chiang JY
Curr Opin Gastroenterol; 2015 Mar; 31(2):159-65. PubMed ID: 25584736
[TBL] [Abstract][Full Text] [Related]
7. The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing.
Liu T; Song X; Khan S; Li Y; Guo Z; Li C; Wang S; Dong W; Liu W; Wang B; Cao H
Int J Cancer; 2020 Apr; 146(7):1780-1790. PubMed ID: 31291465
[TBL] [Abstract][Full Text] [Related]
8. Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders.
Fiorucci S; Distrutti E
Trends Mol Med; 2015 Nov; 21(11):702-714. PubMed ID: 26481828
[TBL] [Abstract][Full Text] [Related]
9. Metabolic effects of bile acids in the gut in health and disease.
Boesjes M; Brufau G
Curr Med Chem; 2014; 21(24):2822-9. PubMed ID: 24606522
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice.
Park MY; Kim SJ; Ko EK; Ahn SH; Seo H; Sung MK
J Appl Microbiol; 2016 Sep; 121(3):800-10. PubMed ID: 27111464
[TBL] [Abstract][Full Text] [Related]
11. Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship.
Ridlon JM; Alves JM; Hylemon PB; Bajaj JS
Gut Microbes; 2013; 4(5):382-7. PubMed ID: 23851335
[TBL] [Abstract][Full Text] [Related]
12. Bile Acid Physiology.
Di Ciaula A; Garruti G; Lunardi Baccetto R; Molina-Molina E; Bonfrate L; Wang DQ; Portincasa P
Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s4-s14. PubMed ID: 29080336
[TBL] [Abstract][Full Text] [Related]
13. Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism.
Wahlström A; Sayin SI; Marschall HU; Bäckhed F
Cell Metab; 2016 Jul; 24(1):41-50. PubMed ID: 27320064
[TBL] [Abstract][Full Text] [Related]
14. Consequences of bile salt biotransformations by intestinal bacteria.
Ridlon JM; Harris SC; Bhowmik S; Kang DJ; Hylemon PB
Gut Microbes; 2016; 7(1):22-39. PubMed ID: 26939849
[TBL] [Abstract][Full Text] [Related]
15. Bile Acid Metabolism in Liver Pathobiology.
Chiang JYL; Ferrell JM
Gene Expr; 2018 May; 18(2):71-87. PubMed ID: 29325602
[TBL] [Abstract][Full Text] [Related]
16. Dietary fat, bile acid metabolism and colorectal cancer.
Ocvirk S; O'Keefe SJD
Semin Cancer Biol; 2021 Aug; 73():347-355. PubMed ID: 33069873
[TBL] [Abstract][Full Text] [Related]
17. Interplay between bile acids and the gut microbiota promotes intestinal carcinogenesis.
Wang S; Dong W; Liu L; Xu M; Wang Y; Liu T; Zhang Y; Wang B; Cao H
Mol Carcinog; 2019 Jul; 58(7):1155-1167. PubMed ID: 30828892
[TBL] [Abstract][Full Text] [Related]
18. Analysis of metabolome changes in the bile acid pool in feces and plasma of antibiotic-treated rats.
Behr C; Slopianka M; Haake V; Strauss V; Sperber S; Kamp H; Walk T; Beekmann K; Rietjens IMCM; van Ravenzwaay B
Toxicol Appl Pharmacol; 2019 Jan; 363():79-87. PubMed ID: 30502395
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice.
Hartmann P; Hochrath K; Horvath A; Chen P; Seebauer CT; Llorente C; Wang L; Alnouti Y; Fouts DE; Stärkel P; Loomba R; Coulter S; Liddle C; Yu RT; Ling L; Rossi SJ; DePaoli AM; Downes M; Evans RM; Brenner DA; Schnabl B
Hepatology; 2018 Jun; 67(6):2150-2166. PubMed ID: 29159825
[TBL] [Abstract][Full Text] [Related]
20. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
